Clinical trial · Observational
Relationship of Nutritional Status to Chemotherapy Treatment Completion and Outcomes in Cancer Patients
Evaluate the Relationship of Nutritional Status to Chemotherapy Treatment Completion Rates and Outcomes in Real-life Conditions in Patients With Metastatic and Non-metastatic Gastric, Colon, and Lung Cancer.
NCT07059598CI-TRIAL-00092051completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This non-interventional, prospective, non-drug observational study is designed to observe the effect of the nutritional status of metastatic and non-metastatic gastric, colon and lung cancer patients on their cancer chemotherapy treatment completion rates.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer-related Malnutrition | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (0)
[]Primary outcomes (2)
- measure
- RMAPP
- timeFrame
- Baseline to week 24
- description
- A tool to screen patients for risk of malnutrition and/or sarcopenia
- measure
- PG-SGA
- timeFrame
- Baseline to week 24
- description
- Healthcare Professional completed assessment resulting in score where A = Well Nourished, B = Moderately Malnourished, and C = Severely Malnourished
Secondary outcomes (8)
- measure
- Weight
- timeFrame
- Baseline to 24 weeks
- description
- Change in weight
- measure
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Subject or subject's legally acceptable representative (LAR) has voluntarily signed and dated an ICF approved by an IEC, or any other applicable privacy authorization prior to any participation in the study. * Ambulatory and inpatient subject. * Subject recently (within the last month) or newly diagnosed to have metastatic or non-metastatic gastric, colon and lung cancer. * Subject is recently receiving chemotherapy or recently prescribed to begin chemotherapy treatment per standard of care (within the last month) or candidates who will receive chemotherapy. * Subject has a life expectancy greater than 6 months. Exclusion Criteria: * Subject has known dementia, brain metastases, eating disorders, history of significant neurological or psychiatric disorder, any other psychological condition, serious illness or medical condition that may interfere with study completion. * Subject has malignant tumors other than treated DCIS, fully treated non-melanoma skin cancer, curatively resected in-situ cervical cancer or other curative treated tumors (except stomach, colon and lung cancer) for \> 5 years. * Subject has bone marrow metastasis. * Subject is lactating. * Subject is participating in another study that has not been approved as a concomitant study.
References
Publications (0)
Data not yet available
No reference posted for this study.